Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-23

Clinical Trial Update: Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examining reinfection rates of hepatitis C in incarcerated individuals after cure with interferon-free hepatitis C treatment, co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Hepatitis C Virus | Phase 4 | Status: ACTIVE_NOT_RECRUITING